08/01/2008
James J. Ferguson, III, MD; James P. Zidar, MD; Glenn N. Levine, MD; James E. Tcheng, MD; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI; Gideon Bosker, MD; Gary L. Schaer, MD, FACC, FSCAI; Dean J. Kereiakes, MD, FACC, MSCAI; Jose G. Diez, MD; Edward T.A. Fry, MD
A total of 5,225 patients were enrolled in the PARAGON B trial. Among these patients, the type of heparin used was known in 5,200 (99.5%). The median duration of therapy was 72.8 hours for UFH and 79.7 hours for LMWH. LMWH was used in about...
A total of 5,225 patients were enrolled in the PARAGON B trial. Among these patients, the type of heparin used was known in 5,200 (99.5%). The median duration of therapy was 72.8 hours for UFH and 79.7 hours for LMWH. LMWH was used in about...
A total of 5,225 patients were...
